HB4438: John W. Walsh Alpha-1 Home Infusion Act of 2023
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
To amend title XVIII of the Social Security Act to provide for coverage and payment of Alpha-1 Antitrypsin Deficiency Disorder treatment under part B of such title, and for other purposes.
Plain-language summary
This bill would expand Medicare Part B coverage to include treatment for Alpha-1 Antitrypsin Deficiency Disorder (a genetic lung disease) given at home. Currently, Medicare covers this treatment only in clinical settings. The bill directs the Centers for Medicare and Medicaid Services to pay for home-based infusion therapy for eligible patients. The bill is currently in the introduction stage with support from members of both parties. It aims to make treatment more convenient and accessible for Medicare beneficiaries with this condition.
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
HB4438: John W. Walsh Alpha-1 Home Infusion Act of 2023
Upcoming hearings & events
Sponsors
Maria Salazar
Primary SponsorCo-sponsors (59)
Chellie Pingree
Bill Posey
Paul Tonko
Debbie Wasserman Schultz
William Keating